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Letters to the EditorTHERAPEUTIC EFFECT OF
ATROPINE 1% IN CHILDREN
WITH LOW MYOPIATo the Editor: We congratulate Yi and colleagues1 on their
successful use of atropine 1% to control myopia, which is
rare inmainlandChina.However, there are several questions
to address. First, the authors indicate that 6 patients (8%)
withdrew from the treatment group and 2 (3%) from the con-
trol group, but Table 1 indicates that 68 subjects are in the
treatment group and 64 in normal group withdrew. Second,
there was a reduction of myopia by 0.32  0.22 D in the
atropine group; in addition, the axial length was 0.03 
0.07 mm compared with baseline after 1 year. Atropine has
beenmuch discussed recently and has been reported to effec-
tively control myopia2; however, this report suggests that it
can even reverse myopia, as indicated by the authors’ Fig-
ures 2 and 3. These results are surprising, and we wonder
how and why this was possible? Third, atropine has been re-
ported to have dose-related side effects, although none were
reported in this research: 1% atropine is a relatively high
dose, and adverse effects might be expected. Therefore,
data on accommodation amplitude, near vision and, low-
dose atropine treatment would be helpful.3 Finally, the
authors assert in their discussion that uncorrecteddistance vi-
sual acuity in 35of 68 patients in the atropine groupwas#0.3
(20/40). These 35 patients should be able to see clearly
without glasses for most tasks. However, for children 7-12
years of age, visual acuity #0.3 is below normal and glasses
may be important. Photophobia could also be a problem
requiring the use of photochromatic glasses.
Qianwen Gong, PhD
Longqian Liu, MD, PhD
Department of Optometry
West China Hospital Sichuan University
China
References
1. Yi S, Huang Y, Yu SZ, Chen XJ, Yi H, Zeng XL. Therapeutic effect of
atropine 1% in children with low myopia. J AAPOS 2015;19:426-9.
2. Shih KC, Chan TC, Ng AL, et al. Use of atropine for prevention of
childhood myopia progression in clinical practice. Eye Contact Lens
2016;42:16-23.
3. Chia A, LuQS,TanD. Five-Year clinical trial on atropine for the treat-




Copyright  2016 by the American Association for Pediatric Ophthalmology and
Strabismus.
1091-8531/$36.00DENSITY OF THE
CRYSTALLINE LENS IN OBESE
AND NONOBESE CHILDRENTo the Editor: Acer and colleauges1 evaluated crystalline
lens density in obese and nonobese children by PentacamJournal of AAPOSHR and found that lens density was higher in obese chil-
dren than in normal controls in 7- to 14-year-olds but no
different in 15- to 18-year-olds. If obesity causes an in-
crease in lens density, we would expect density to increase
with age; the absence of difference between obese and
normal controls in the older group is interesting.
A strong link between obesity and cataract has been re-
ported in several studies.2 Osmotic stress, oxidative stress,
and nonenzymatic glycation of lens proteins are accepted
mechanisms for the development of cataract. Obesity
may influence all of these pathologic pathways.3 Difference
in glucose metabolism between obese and nonobese chil-
drenmay be the cause of difference in lens densities. Lenses
of obese children are exposed tomore glucose than those of
nonobese children. This greater exposure may explain the
difference between obese children and controls in 7- to 14-
year-olds. During puberty, increase in hormone levels may
affect glucose metabolism. Growth hormone levels rise
during puberty and increase blood glucose levels. Hyperin-
sulinemia is a characteristic finding of obesity. The effects
of growth hormone may counterbalanced by insulin in
obese chilren.4 As a result of this situation, both lenses of
obese and nonobese children may be exposed to the same
levels of glucose during puberty. While 15-18 years does
not exactly correspond to puberty, the relationship be-
tween growth hormone and insulin may explain the
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1091-8531/$36.00REPLYWe would like to thank Dr. Kaya for his interest in our
article. He points out that obesity may affect several path-
ologic pathways of cataract formation. We presented
increased lens density levels in obese children compared
with nonobese children.1 There was a positive correlation379
380 Letters to the Editor Volume 20 Number 4 / August 2016between lens density and BMI, age, and the pubertal stage.
However, in our subgroup analysis according to age,
although the lens density levels were significantly higher
in children under the age of 15 years, the difference was
not significant in children over the age of 15 in the obese
subgroups compared with the controls.1 This outcome
might be occurred due to the low number of participants
in the subgroups.
Dr. Kaya suggests that the increased lens density in
obese children younger than 15 years may be the result
of high glucose exposure of the lenses. Nevertheless,
increased insulin and growth hormone levels during pu-
berty may balance blood glucose levels, resulting in normal
lens density in older children.We do not knowwhether the
lenses of obese children are exposed to more glucose than
those of nonobese children younger than 15 years. We
excluded diabetic children, and the blood glucose levels
of all of the children were within normal limits in our study
groups.1 It is true that growth hormone levels increase
during puberty and that the growth hormone increases
blood glucose levels2-3; however, the blood glucose levels
are within normal limits in non diabetic children during
puberty.4 Hyperinsulinemia is an often finding of child-
hood obesity.5We reanalyzed some of our findings accord-
ing to Dr. Kaya’s suggestions. When we compared all the
children in terms of hyperinsulinemia, there was no signif-
icant difference in lens density measurements between the
children with and without hyperinsulinemia (P . 0.05).
We agree that levels of growth hormone or some other
hormones, such as sex hormones, may affect the lens
density in obese children. In addition, many other factors
such as nutritional status, prematurity, dehydration, and
accommodation problems may affect lens density of
children. However, we have no data about hormone levels
other than for insulin in our study; therefore, we are not
able to explain the changes in lens density in children inour study with the association between insulin levels and
the growth hormone or other hormones.
Semra Acer, MD
G€okhan Pekel, MD
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